Nanotechnology, 9 4 , , Kumbar, Sangamesh Sangamesh G. Polymeric micro-nanostructures for tissue regeneration and drug delivery applications. Part A Aug; 82 2: These amphiphilic prodrugs self-assemble and form micelles possess the ability to deliver multiple drugs and can be easily functionalized for active targeting.
|License:||For Personal Use Only|
|iPhone 5, 5S resolutions||640×1136|
|iPhone 6, 6S resolutions||750×1334|
|iPhone 7, 7 Plus, 8, 8 Plus resolutions||1080×1920|
|Android Mobiles HD resolutions||360×640, 540×960, 720×1280|
|Android Mobiles Full HD resolutions||1080×1920|
|Mobiles HD resolutions||480×800, 768×1280|
|Mobiles QHD, iPhone X resolutions||1440×2560|
|HD resolutions||1280×720, 1366×768, 1600×900, 1920×1080, 2560×1440, Original|
Soft Matter Jan; 6 Summer ’19, Fall ’19, Spring ‘ Kumbar has developed several biodegradable poly anhydride based elastic materials and nanofiber scaffolds for variety of soft tissue regeneration applications. Polymeric micro-nanostructures for sangamesn regeneration and drug delivery applications.
Such delivery systems can significantly improve the performance of chemotherapeutic drugs and contribute to prolonging a good quality of life. Chemotherapeutic drugs used currently possess several drawbacks such as poor solubility and non-specificity requiring high drug doses to attain therapeutic concentration.
Advanced Functional Materials Jan; sanyamesh 9: Karnatak University Physical Chemistry Ph. Tissue engineering seeks to design tissue substitutes for clinical use to overcome the limitations associated with autografts and allografts. Biomedical Engineering Department A. This platform can produce numerous chemotherapeutic drug formulations for cancer treatment. More information on current projects can be found on my website.
Natural and Synthetic Biomedical Polymers. Polymeric materials namely polysaccharides, polyposphazenes, polyanhydrides, polyesters as well as blends of two or more of the polymeric materials and composites sanhamesh the polymeric materials with ceramics in the form of 3-dimentional porous structures will serve as scaffolds for variety of tissue engineering applications. Natural polymer scaffolds may saangamesh minimize chronic inflammation or immunological reactions and toxicity sangamssh associated with synthetic polymer scaffolds.
Healing bone using a biomimetic tubular sintered microsphere matrix: Technologies and Applications Jan; Part A Dec; 95 4: Scaffold-based tissue engineering has become a promising strategy to regenerate three-dimensional 3-D tissues for transplantation.
Nanotechnology Jan; 45 Contemporary drug delivery systems comprised of nanoparticles, liposomes and sagnamesh can reduce non-specific systemic toxicity, however, targeting cancer cells still remains a challenge. This platform can produce numerous chemotherapeutic drug formulations for cancer treatment.
Bioactive Polysaccharide Bone Grafts: Natural polymer scaffolds may also minimize chronic inflammation or immunological reactions and toxicity often associated with synthetic polymer scaffolds. Ex vivo gene therapy in combination with a novel tubular sintered microsphere scaffold: Acrylic-based ph-sensitive superabsobents sangamwsh controlled release of a pesticide and a micronutrient.
Kumbar, Sangamesh Sangamesh G. School of Engineering Biomedical Engineering Department. A wide range of synthetic and natural polymers have already been adopted for 3-D scaffold fabrication.
Contemporary drug delivery systems comprised of nanoparticles, liposomes and micelles can reduce non-specific systemic toxicity, however, targeting cancer cells still remains a challenge. Nanotechnology, 9 4, Scaffold-based tissue engineering has become a promising strategy to regenerate three-dimensional 3-D tissues for transplantation.
Faculty Directory › UConn Health
Synthesis and characterization of novel biodegradable phenyl phenoxy-based polyphosphazene blends: Prodrug and targeting concept based on the polyphosphazene platform provides numerous opportunities to synthesize several cytotoxic drugs with improved clinical performance. Active drug will be generated at the site of action following peptide drug cleavage from the polymer backbone in the tumor environment and lysosomal peptide spacer degradation.
The Scaffold Jan; Part A Aug; 82 2: